We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

pF9A CMV hRluc-neo Flexi® Vector Product Information

  • Instructions for Use of Product(s)
  • C9361

Literature # 9PIC936

The pF9A CMV hRluc-neo Flexi® Vector is designed for use with the Flexi® System, Entry/Transfer (Cat.#C8640) and the Flexi® System, Transfer (Cat.# C8820). The vector contains a CMV immediate early enhancer/promoter region plus a chimeric intron for mammalian expression, and a T7 promoter for in vitro expression of the protein-coding region. In addition, the vector contains a barnase gene for positive selection of the insert, an ampicillin-resistance gene for selection of the plasmid and unique SgfI and PmeI sites that allow easy insertion and transfer of the insert of interest. The pF9A CMV hRluc-neo Flexi® Vector also contains a unique neomycin-resistance gene fused with a humanized Renilla luciferase (hRluc) gene, under the control of the SV40 promoter, allowing long-term selection of transfected mammalian cells and the ability to monitor those selected cells using a Renilla luciferase assay. Transfection of the pF9A CMV hRluc-neo Flexi® Vector containing a protein-coding region into mammalian cells provides resistance to the antibiotic G-418 (Cat.# V7981 or V8091) and allows selection of transfectants.

Printed in USA. Revised 1/09.

 

PDF Icon Complete Protocol PDF (74kb)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.